1.1 ABIM Critical Care Medicine Exam: Format, Blueprint & Study Strategy

What the Exam Is

The ABIM Critical Care Medicine (CCM) Certification Examination is the American Board of Internal Medicine subspecialty exam for internists who have finished accredited critical care training. It tests whether you can recognize, prioritize, and manage life-threatening illness across the whole ICU: shock, respiratory failure and ventilation, kidney and metabolic emergencies, cardiovascular disease, infection, neurocritical care, surgical and obstetric critical care, hematology and oncology, toxicology, ethics, and bedside ultrasound.

This guide is independent study material by OpenExamPrep. It is not affiliated with or endorsed by ABIM; always confirm logistics on ABIM's own pages before you register.

Format and Logistics

Because there is no penalty for guessing beyond the lost point, answer every item. With roughly 500 minutes of testing time for up to 240 questions, plan on about two minutes per question, and flag long hemodynamic or ventilator vignettes to revisit rather than stalling on them.

Eligibility in Brief

• Internal medicine certification: you must already hold ABIM certification in internal medicine.
• Training: a stand-alone critical care fellowship requires 24 months of training with at least 12 months of clinical critical care. A combined pulmonary and critical care fellowship requires 36 months with at least 18 months of clinical training. Combined trainees can sit for pulmonary disease after two of their three years, but take the CCM exam only after completing all three; pulmonary certification is not required first.
• Timing: training must be completed by October 31 of the exam year.
• Board Eligible window: candidates have 7 years of Board Eligible status after completing training.
• Procedures: program directors attest to competence in airway management and intubation, invasive and noninvasive ventilation, chest tubes and thoracentesis, advanced cardiac life support, and arterial, central venous, and pulmonary artery catheter placement with hemodynamic recording. Ultrasound guidance for line placement and thoracentesis is strongly recommended, and familiarity with pericardiocentesis, transvenous pacing, kidney replacement therapy, and bronchoscopy is expected.
• CCM certification is the prerequisite for ABIM's Neurocritical Care certification.

The January 2026 Blueprint

The current CCM certification blueprint (dated January 2026, used from the fall 2026 exam) divides the exam into 12 content categories and 96 second-level topics:

ABIM also tags each question by task:

• Treatment and care decisions: 50%.
• Diagnosis and testing: 40%.
• Risk assessment, prognosis, and epidemiology: 5%.
• Pathophysiology and basic science: 5%.

The heaviest second-level topics are:

• Mechanical ventilation: 6%.
• Distributive shock: 5%.
• Cardiogenic shock: 4%.
• 3% each: hypovolemic shock, obstructive shock, acid-base disorders, acute kidney injury, hemodynamic monitoring, parenchymal lung disease, and cerebrovascular disease.

Every other topic carries less than about 2.5%.

How to Use the Weights

1. Front-load the core. Shock, pulmonary, renal/metabolic, and cardiovascular content make up 58% of the exam. Master ventilator management, vasopressor and inotrope selection, fluid responsiveness, acid-base analysis, and AKI/kidney replacement therapy first.

2. Train for "what next." Half the questions ask for the best treatment step. When you read a vignette, decide the physiology first (for example, "this is pressure-overload RV failure"), then pick the intervention that fixes the limiting problem without causing harm.

3. Do not skip the long tail. The 1–2% topics, such as bioterrorism, tick paralysis, HIPAA, IRB rules, and normothermic regional perfusion, are individually small but collectively large. Each usually rests on one or two decisive facts.

4. Know what changed recently. Recent sources include:

   • The 2026 Surviving Sepsis Campaign guideline.
   • The 2026 AHA/ACC pulmonary embolism guideline (Categories A–E).
   • The 2026 AHA/ASA acute ischemic stroke guideline.
   • The 2025 AHA post-cardiac arrest care update.
   • The 2025 PADIS focused update.
   • The 2023 adult and pediatric brain death guideline.

   Andexanet alfa was withdrawn from the US market in December 2025, so 4-factor PCC is now the default for reversing factor Xa inhibitors.

5. Practice integration. Many items span categories: a septic patient with ARDS, AKI, and delirium can test four content areas at once.

Sample 12-Week Plan

ABIM's first-time pass rates for CCM in recent years were:

Most well-prepared fellows pass, but roughly one in seven first-time takers did not in 2023 and 2025. Targeted, blueprint-weighted review is the margin.